Early-onset sepsis remains a common and serious problem for neonates, especially preterm
infants. Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia …

Early-onset sepsis (EOS) remains a serious and often fatal illness among infants born
preterm, particularly among newborn infants of the lowest gestational age. Currently, most …

Importance Early-onset sepsis (EOS) remains a potentially fatal newborn condition. Ongoing
surveillance is critical to optimize prevention and treatment strategies. Objective To describe …

Background: To evaluate the efficacy of serial mean platelet volume (MPV) measurements in
diagnosis and follow-up of sepsis and to compare its effectiveness with C-reactive protein …

Interleukin (IL)-18 is an important effector of innate and adaptive immunity, but its expression
must also be tightly regulated because it can potentiate lethal systemic inflammation and …

Background: Most very low birth weight (VLBW, birth weight< 1500 g) infants receive empiric
antibiotics for risk of early-onset sepsis (EOS). The objective of this study was to determine …

Sepsis-related morbidity and mortality are increasing concerns in all Neonatal Intensive
Care Units, with reported incidences that are dramatically high regardless of the …

BACKGROUND: Data are limited on the impact of methicillin-resistant Staphylococcus
aureus (MRSA) on morbidity and mortality among very low birth weight (VLBW) infants with …

Background: Group B Streptococcus (GBS) and Escherichia coli cause serious bacterial
infections (SBIs) and are associated with morbidity and mortality in newborn infants …

The extreme vulnerability of preterm infants to invasive microbial infections has been
attributed to “immature” innate immune defenses. Monocytes are important innate immune …